These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 20930313)
1. In vivo detection of amyloid plaques in the mouse brain using the near-infrared fluorescence probe THK-265. Okamura N; Mori M; Furumoto S; Yoshikawa T; Harada R; Ito S; Fujikawa Y; Arai H; Yanai K; Kudo Y J Alzheimers Dis; 2011; 23(1):37-48. PubMed ID: 20930313 [TBL] [Abstract][Full Text] [Related]
2. Efficient near-infrared in vivo imaging of amyoid-β deposits in Alzheimer's disease mouse models. Schmidt A; Pahnke J J Alzheimers Dis; 2012; 30(3):651-64. PubMed ID: 22460331 [TBL] [Abstract][Full Text] [Related]
3. A Novel Near-Infrared Fluorescence Probe THK-565 Enables In Vivo Detection of Amyloid Deposits in Alzheimer's Disease Mouse Model. Naganuma F; Murata D; Inoue M; Maehori Y; Harada R; Furumoto S; Kudo Y; Nakamura T; Okamura N Mol Imaging Biol; 2023 Dec; 25(6):1115-1124. PubMed ID: 37580462 [TBL] [Abstract][Full Text] [Related]
4. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain. Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164 [TBL] [Abstract][Full Text] [Related]
5. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Güntert A; Döbeli H; Bohrmann B Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022 [TBL] [Abstract][Full Text] [Related]
6. Molecular imaging of β-amyloid plaques with near-infrared boron dipyrromethane (BODIPY)-based fluorescent probes. Watanabe H; Ono M; Matsumura K; Yoshimura M; Kimura H; Saji H Mol Imaging; 2013; 12(5):338-47. PubMed ID: 23759374 [TBL] [Abstract][Full Text] [Related]
7. In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe. Hintersteiner M; Enz A; Frey P; Jaton AL; Kinzy W; Kneuer R; Neumann U; Rudin M; Staufenbiel M; Stoeckli M; Wiederhold KH; Gremlich HU Nat Biotechnol; 2005 May; 23(5):577-83. PubMed ID: 15834405 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice. Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020 [TBL] [Abstract][Full Text] [Related]
10. Highly Sensitive Near-Infrared Fluorophores for in Vivo Detection of Amyloid-β Plaques in Alzheimer's Disease. Fu H; Cui M; Zhao L; Tu P; Zhou K; Dai J; Liu B J Med Chem; 2015 Sep; 58(17):6972-83. PubMed ID: 26262759 [TBL] [Abstract][Full Text] [Related]
11. Smart near-infrared fluorescence probes with donor-acceptor structure for in vivo detection of β-amyloid deposits. Cui M; Ono M; Watanabe H; Kimura H; Liu B; Saji H J Am Chem Soc; 2014 Mar; 136(9):3388-94. PubMed ID: 24555862 [TBL] [Abstract][Full Text] [Related]
12. Detection of Aβ plaques by a novel specific MRI probe precursor CR-BSA-(Gd-DTPA)n in APP/PS1 transgenic mice. Li S; He H; Cui W; Gu B; Li J; Qi Z; Zhou G; Liang CM; Feng XY Anat Rec (Hoboken); 2010 Dec; 293(12):2136-43. PubMed ID: 21089051 [TBL] [Abstract][Full Text] [Related]
13. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. van Groen T; Kiliaan AJ; Kadish I Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo staining characteristics of small, fluorescent, Abeta42-binding D-enantiomeric peptides in transgenic AD mouse models. van Groen T; Kadish I; Wiesehan K; Funke SA; Willbold D ChemMedChem; 2009 Feb; 4(2):276-82. PubMed ID: 19072935 [TBL] [Abstract][Full Text] [Related]
15. Immunomodulation of AβPP processing alleviates amyloid-β-related pathology in Alzheimer's disease transgenic mice. Arbel-Ornath M; Becker M; Rabinovich-Toidman P; Gartner M; Solomon B J Alzheimers Dis; 2010; 22(2):469-82. PubMed ID: 20847413 [TBL] [Abstract][Full Text] [Related]
16. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library. Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663 [TBL] [Abstract][Full Text] [Related]
17. The Arctic amyloid-β precursor protein (AβPP) mutation results in distinct plaques and accumulation of N- and C-truncated Aβ. Philipson O; Lord A; Lalowski M; Soliymani R; Baumann M; Thyberg J; Bogdanovic N; Olofsson T; Tjernberg LO; Ingelsson M; Lannfelt L; Kalimo H; Nilsson LN Neurobiol Aging; 2012 May; 33(5):1010.e1-13. PubMed ID: 22118948 [TBL] [Abstract][Full Text] [Related]
18. Rapid cerebral amyloid binding by Aβ antibodies infused into β-amyloid precursor protein transgenic mice. Winkler DT; Abramowski D; Danner S; Zurini M; Paganetti P; Tolnay M; Staufenbiel M Biol Psychiatry; 2010 Nov; 68(10):971-4. PubMed ID: 20359696 [TBL] [Abstract][Full Text] [Related]
19. Diphenylpropynone derivatives as probes for imaging β-amyloid plaques in Alzheimer's brains. Ono M; Watanabe H; Watanabe R; Haratake M; Nakayama M; Saji H Bioorg Med Chem Lett; 2011 Jan; 21(1):117-20. PubMed ID: 21145738 [TBL] [Abstract][Full Text] [Related]
20. Fluorescent 2-styrylpyridazin-3(2H)-one derivatives as probes targeting amyloid-beta plaques in Alzheimer's disease. Park YD; Park JH; Hur MG; Kim SW; Min JJ; Park SH; Yoo YJ; Yoon YJ; Yang SD Bioorg Med Chem Lett; 2012 Jun; 22(12):4106-10. PubMed ID: 22578456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]